Literature DB >> 22394559

Thyrotoxicosis.

Jayne A Franklyn1, Kristien Boelaert.   

Abstract

Thyrotoxicosis is a common disorder, especially in women. The most frequent cause is Graves' disease (autoimmune hyperthyroidism). Other important causes include toxic nodular hyperthyroidism, due to the presence of one or more autonomously functioning thyroid nodules, and thyroiditis caused by inflammation, which results in release of stored hormones. Antithyroid drugs are the usual initial treatment (thionamides such as carbimazole or its active metabolite methimazole are the drugs of choice). A prolonged course leads to remission of Graves' hyperthyroidism in about a third of cases. Because of the low remission rate in Graves' disease and the inability to cure toxic nodular hyperthyroidism with antithyroid drugs alone, radioiodine is increasingly used as first line therapy, and is the preferred choice for relapsed Graves' hyperthyroidism. Total thyroidectomy is an option in selected cases. Future efforts are likely to concentrate on novel and safe ways to modulate the underlying disease process rather than stopping excess thyroid hormone production. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22394559     DOI: 10.1016/S0140-6736(11)60782-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  72 in total

1.  A Rare Clinical Manifestation of Graves' Disease: Evans Syndrome and a Review of the Literature.

Authors:  M Calapkulu; M E Sencar; A Yıldız; I O Unsal; E Cakal
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

Review 2.  Diagnosis and management of Graves disease: a global overview.

Authors:  Luigi Bartalena
Journal:  Nat Rev Endocrinol       Date:  2013-10-15       Impact factor: 43.330

3.  Periodic Granulocyte Count Measuring Is Useful for Detecting Asymptomatic Agranulocytosis in Antithyroid Drug-Treated Patients with Graves' Disease.

Authors:  Hirotoshi Nakamura; Akane Ide; Takumi Kudo; Eijun Nishihara; Mitsuru Ito; Akira Miyauchi
Journal:  Eur Thyroid J       Date:  2016-09-06

4.  Primary anestrus due to dietary hyperthyroidism in a miniature pinscher bitch.

Authors:  Besim Hasan Sontas; Ilse Schwendenwein; Sabine Schäfer-Somi
Journal:  Can Vet J       Date:  2014-08       Impact factor: 1.008

5.  An unusual presenting symptom of graves' disease: myalgia.

Authors:  N Papanikolaou; P Perros
Journal:  Eur Thyroid J       Date:  2012-11-15

6.  TAS2R bitter taste receptors regulate thyroid function.

Authors:  Adam A Clark; Cedrick D Dotson; Amanda E T Elson; Anja Voigt; Ulrich Boehm; Wolfgang Meyerhof; Nanette I Steinle; Steven D Munger
Journal:  FASEB J       Date:  2014-10-23       Impact factor: 5.191

7.  Topical L-thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?

Authors:  Ralf Paus; Yuval Ramot; Robert S Kirsner; Marjana Tomic-Canic
Journal:  Exp Dermatol       Date:  2020-08-28       Impact factor: 3.960

8.  Survey of Clinical Practice Patterns in the Management of 992 Hyperthyroid Patients in France.

Authors:  Bernard Goichot; Stéphane Bouée; Claire Castello-Bridoux; Philippe Caron
Journal:  Eur Thyroid J       Date:  2017-01-05

9.  Pulmonary hypertension in a pregnant patient with thyrotoxicosis due to Graves' disease: considerations with respect to treatment.

Authors:  Vanja Mathot; Erik Oosterwerff; Mariëlle G van Pampus; Robert Riezebos
Journal:  BMJ Case Rep       Date:  2014-02-13

10.  Fatty acid metabolism and thyroid hormones.

Authors:  Naomi L Sayre; James D Lechleiter
Journal:  Curr Trends Endocinol       Date:  2012-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.